GoldmanSachs had a problem. It was early 2017, and Marquee, a trading and risk-management platform in which the firm had invested millions with the hopes of turning it into its next big ...
GoldmanSachs analysts push back their projected timeline for gold (GC=F) to reach $3,000 to the second quarter of 2026 and have now set their 2025 year-end target to $2,910.
The tradingplatforms of Deutsche Börse, GoldmanSachs and others connected will be connected by the Canton Network, some of whose monthly notional traded exceeds the most active crypto token ...
GoldmanSachs Group Inc (NYSE:GS). is actively exploring strategic options for its ETF Accelerator platform, which may include a potential sale, according to reports from Bloomberg and Reuters.
GoldmanSachs has initiated Vaxcyte with a buy rating highlighting the company's vaccine platform and lead candidate for pneumonia. The firm has a $135 price target (~57% upside based on Dec. 19 ...
Some results have been hidden because they may be inaccessible to you